Details for Patent: 5,312,925
✉ Email this page to a colleague
Summary for Patent: 5,312,925
Title: | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dih ydro-2H-indol-2-one-hydrochloride |
Abstract: | The monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydr o-2H-indole-2-one hydrochloride has advantageous stability for formulation as a neuroleptic agent. |
Inventor(s): | Allen; Douglas J. M. (New London, CT), Busch; Frank R. (Gales Ferry, CT), DiRoma; Sabeto A. (Uncasville, CT), Godek; Dennis M. (Glastonbury, CT) |
Assignee: | Pfizer Inc. (New York, NY) |
Application Number: | 07/939,204 |
Patent Claim Types: see list of patent claims | Compound; Use; Composition; Process; |
Drugs Protected by US Patent 5,312,925
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,312,925
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 206422 | ⤷ Try a Trial | |||
Austria | 273976 | ⤷ Try a Trial | |||
Australia | 4600493 | ⤷ Try a Trial | |||
Australia | 642836 | ⤷ Try a Trial | |||
Australia | 657231 | ⤷ Try a Trial | |||
Brazil | 9302065 | ⤷ Try a Trial | |||
Brazil | 9303014 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |